A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

Inclusion Criteria

• •Age less than 21 years at diagnosis
• •Previously untreated, pathologically confirmed diagnosis of Hodgkin's disease.
• •Informed patient/parental consent as required by individual institution and in accordance with the Dept of Health and Human Services
• •Approval of this protocol by the individual institutional Human Subjects Review Committee.
• •Indicate Hodgkin's disease clinical stage.
• •Indicate presence or absence of "B" symptoms.
• •For Stage I and II disease indicate the following:
• •presence or absence of bulk disease
• •number of involved nodal regions
• •presence or absence of hilar adenopathy